Is SPDR SP Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, SPDR SP Pharmaceuticals pays dividends. Last time was Wednesday 25th of September 2024 where the investors holding the stock on Monday 23rd of September 2024 were paid $0.19471 per share. Over the last 73 times between 2006 and 2024, SPDR SP Pharmaceuticals has paid $18.7948 with an average of $0.26 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for SPDR SP Pharmaceuticals 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $40.05, you would have made a profit of $5.46 per share or 13.63%
Yes, the average daily trading liquidity for SPDR SP Pharmaceuticals is $48 413 thousand. You should therefore be able to get in and out of your positions relatively fast.
SPDR SP Pharmaceuticals has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for SPDR SP Pharmaceuticals to be medium [0.6 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.